These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28499847)

  • 21. Development of a Health Equity Framework for the US Preventive Services Task Force.
    Lin JS; Webber EM; Bean SI; Evans CV
    JAMA Netw Open; 2024 Mar; 7(3):e241875. PubMed ID: 38466305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protocol for the development of a CONSORT-equity guideline to improve reporting of health equity in randomized trials.
    Welch V; Jull J; Petkovic J; Armstrong R; Boyer Y; Cuervo LG; Edwards S; Lydiatt A; Gough D; Grimshaw J; Kristjansson E; Mbuagbaw L; McGowan J; Moher D; Pantoja T; Petticrew M; Pottie K; Rader T; Shea B; Taljaard M; Waters E; Weijer C; Wells GA; White H; Whitehead M; Tugwell P
    Implement Sci; 2015 Oct; 10():146. PubMed ID: 26490367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of Implementation of a Clinical Practice Guideline for Homeless Health.
    Magwood O; Hanemaayer A; Saad A; Salvalaggio G; Bloch G; Moledina A; Pinto N; Ziha L; Geurguis M; Aliferis A; Kpade V; Arya N; Aubry T; Pottie K
    Int J Environ Res Public Health; 2020 Oct; 17(21):. PubMed ID: 33138054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of the guideline for reporting evidence-based practice educational interventions and teaching (GREET).
    Phillips AC; Lewis LK; McEvoy MP; Galipeau J; Glasziou P; Moher D; Tilson JK; Williams MT
    BMC Med Educ; 2016 Sep; 16(1):237. PubMed ID: 27599967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Informing the GRADE evidence to decision process with health equity considerations: demonstration from the Canadian rheumatoid arthritis care context.
    Barnabe C; Pianarosa E; Hazlewood G
    J Clin Epidemiol; 2021 Oct; 138():147-155. PubMed ID: 34161803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Fertil Steril; 2018 Aug; 110(3):364-379. PubMed ID: 30033227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise].
    Schünemann F; Meerpohl JJ; Schwingshackl L; Kopp IB; Schünemann HJ
    Z Evid Fortbild Qual Gesundhwes; 2021 Jun; 163():76-84. PubMed ID: 34023244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equity issues rarely addressed in the development of COVID-19 formal recommendations and good practice statements: a cross-sectional study.
    Dewidar O; Bondok M; Abdelrazeq L; Aliyeva K; Solo K; Welch V; Brignardello-Petersen R; Mathew JL; Hazlewood G; Pottie K; Hartling L; Khalifa DS; Duda S; Falavigna M; Khabsa J; Lotfi T; Petkovic J; Elliot S; Chi Y; Parker R; Kristjansson E; Riddle A; Darzi AJ; Magwood O; Saad A; Rada G; Neumann I; Loeb M; Reveiz L; Mertz D; Piggott T; Turgeon AF; Schünemann H; Tugwell P
    J Clin Epidemiol; 2023 Sep; 161():116-126. PubMed ID: 37562727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Taking an integrated knowledge translation approach in research to develop the CONSORT-Equity 2017 reporting guideline: an observational study.
    Jull J; Graham ID; Kristjansson E; Moher D; Petkovic J; Yoganathan M; Tugwell P; Welch VA;
    BMJ Open; 2019 Jul; 9(7):e026866. PubMed ID: 31366641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving the use of research evidence in guideline development: 16. Evaluation.
    Oxman AD; Schünemann HJ; Fretheim A
    Health Res Policy Syst; 2006 Dec; 4():28. PubMed ID: 17156460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying target audiences: who are the guidelines for? : article 1 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Yawn BP; Akl EA; Qaseem A; Black P; Campos-Outcalt D;
    Proc Am Thorac Soc; 2012 Dec; 9(5):219-24. PubMed ID: 23256162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No. 367-2019 Canadian Guideline for Physical Activity throughout Pregnancy.
    Mottola MF; Davenport MH; Ruchat SM; Davies GA; Poitras V; Gray C; Jaramillo Garcia A; Barrowman N; Adamo KB; Duggan M; Barakat R; Chilibeck P; Fleming K; Forte M; Korolnek J; Nagpal T; Slater L; Stirling D; Zehr L
    J Obstet Gynaecol Can; 2018 Nov; 40(11):1528-1537. PubMed ID: 30297272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement.
    Chen Y; Yang K; Marušic A; Qaseem A; Meerpohl JJ; Flottorp S; Akl EA; Schünemann HJ; Chan ES; Falck-Ytter Y; Ahmed F; Barber S; Chen C; Zhang M; Xu B; Tian J; Song F; Shang H; Tang K; Wang Q; Norris SL;
    Ann Intern Med; 2017 Jan; 166(2):128-132. PubMed ID: 27893062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reporting of health equity considerations in cluster and individually randomized trials.
    Petkovic J; Jull J; Yoganathan M; Dewidar O; Baird S; Grimshaw JM; Johansson KA; Kristjansson E; McGowan J; Moher D; Petticrew M; Robberstad B; Shea B; Tugwell P; Volmink J; Wells GA; Whitehead M; Cuervo LG; White H; Taljaard M; Welch V
    Trials; 2020 Apr; 21(1):308. PubMed ID: 32245522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic modelling of diagnostic and treatment pathways in National Institute for Health and Care Excellence clinical guidelines: the Modelling Algorithm Pathways in Guidelines (MAPGuide) project.
    Lord J; Willis S; Eatock J; Tappenden P; Trapero-Bertran M; Miners A; Crossan C; Westby M; Anagnostou A; Taylor S; Mavranezouli I; Wonderling D; Alderson P; Ruiz F
    Health Technol Assess; 2013 Dec; 17(58):v-vi, 1-192. PubMed ID: 24325843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methodological guidance for incorporating equity when informing rapid-policy and guideline development.
    Dewidar O; Kawala BA; Antequera A; Tricco AC; Tovey D; Straus S; Glover R; Tufte J; Magwood O; Smith M; Ooi CP; Dion A; Goetghebeur M; Reveiz L; Negrini S; Tugwell P; Petkovic J; Welch V;
    J Clin Epidemiol; 2022 Oct; 150():142-153. PubMed ID: 35863618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of guidelines for good practice in decision-analytic modelling in health technology assessment.
    Philips Z; Ginnelly L; Sculpher M; Claxton K; Golder S; Riemsma R; Woolacoot N; Glanville J
    Health Technol Assess; 2004 Sep; 8(36):iii-iv, ix-xi, 1-158. PubMed ID: 15361314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.
    Teede HJ; Misso ML; Costello MF; Dokras A; Laven J; Moran L; Piltonen T; Norman RJ;
    Hum Reprod; 2018 Sep; 33(9):1602-1618. PubMed ID: 30052961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, grading, and presentation of evidence in guidelines: article 7 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Guyatt G; Akl EA; Oxman A; Wilson K; Puhan MA; Wilt T; Gutterman D; Woodhead M; Antman EM; Schünemann HJ;
    Proc Am Thorac Soc; 2012 Dec; 9(5):256-61. PubMed ID: 23256168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applying a health equity tool to assess a public health nursing guideline for practice in sexually transmitted infection assessment in British Columbia.
    Prescott C; Shahram SZ; Ogilvie G; Hassam N; Franks AS; Pauly B
    Can J Public Health; 2020 Aug; 111(4):610-616. PubMed ID: 32086774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.